Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,329
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Relationship between hepatocellular carcinoma and depression via online database analysis

Tiantian Hana The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-4635-7174
ORCID Icon,
Yingchun Zhoub Clinical laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-1340-113X
ORCID Icon &
Danhua Lib Clinical laboratory, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9168-0395
ORCID Icon
Pages 1689-1697 | Received 23 Feb 2021, Accepted 20 Apr 2021, Published online: 07 May 2021

References

  • Galle P. Extended abstract: management of liver cancer. Dig Dis. 2016;34(4):438–439.
  • Chen W, Dong W, Wang J, et al. Elevated expressions of survivin and endoglin in patients with hepatic carcinoma. Cancer Biother Radiopharm. 2019;34(1):7–12.
  • Fan J, Wang J, Jiang Y, et al. Attributable causes of liver cancer mortality and incidence in China. Asian Pac J Cancer Prev. 2013;14(12):7251–7256.
  • Chen J, Huang S, Li I, et al. Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma. Support Care Cancer. 2019;27(12):4665–4674.
  • Lee K, Lin J, Shi H. Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma: a nationwide study of a cohort from Taiwan. World J Biol Psychiatry. 2018;19(6):431–439.
  • Rakel R. Depression. Prim Care. 1999;26(2):211–224.
  • Jia Y, Li F, Liu Y, et al. Depression and cancer risk: a systematic review and meta-analysis. Public Health. 2017;149:138–148.
  • Barrera I, Spiegel D. Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry. 2014;26(1):31–43.
  • Nikendei C, Terhoeven V, Ehrenthal J, et al. Depression profile in cancer patients and patients without a chronic somatic disease. Psychooncology. 2018;27(1):83–90.
  • Steel J, Geller D, Gamblin T, et al. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007;25(17):2397–2405.
  • Oliver G, Hart S, Klee E. Bioinformatics for clinical next generation sequencing. Clin Chem. 2015;61(1):124–135.
  • McGlynn K, Petrick J, El-Serag H. Epidemiology of hepatocellular carcinoma. Hepatology. 2021 Jan;73 Suppl 11:4–13
  • Cruz-Pereira J, Rea K, Nolan Y, et al. Trinity: dysregulated stress, immunity, and the microbiome. Annu Rev Psychol. 2020;71:49–78.
  • Szelei A, Döme P. Cancer and depression: a concise review. Orv Hetil. 2020;161(22):908–916.
  • Wang Y, Li J, Shi J, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(7):1487–1499.
  • Carneiro B, El-Deiry W. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417.
  • Pentimalli F, Grelli S, Di Daniele N, et al. Cell death pathologies: targeting death pathways and the immune system for cancer therapy. Genes Immun. 2019;20(7):539–554.
  • Ke B, Tian M, Li J, et al. Targeting programmed cell death using small-molecule compounds to improve potential cancer therapy. Med Res Rev. 2016;36(6):983–1035.
  • Li D, Fu J, Du M, et al. Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization. Hepatology. 2016;64(4):1105–1120.
  • Li Y, Jia Y, Wang D, et al. Programmed cell death 4 as an endogenous suppressor of BDNF translation is involved in stress-induced depression. Mol Psychiatry. 2020. DOI:10.1038/s41380-020-0692-x.
  • Idilman R, De Maria N, Colantoni A, et al. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepat. 1998;5(5):285–299.
  • Wang W, Wang Z, Qin Y, et al. Th17, synchronically increased with T and B, promoted by tumour cells via cell-contact in primary hepatic carcinoma. Clin Exp Immunol. 2018;192(2):181–192.
  • Kohler O, Krogh J, Mors O, et al. Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol. 2016;14(7):732–742.
  • Majd M, Saunders E, Engeland C. Inflammation and the dimensions of depression: a review. Front Neuroendocrinol. 2020;56:100800.
  • Halaris A. Inflammation and depression but where does the inflammation come from? Curr Opin Psychiatry. 2019;32(5):422–428.
  • Kondo M, Koyama Y, Nakamura Y, et al. A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects. Mol Psychiatry. 2018;23(4):833–842.
  • Kopczak A, Stalla G, Uhr M, et al. IGF-I in major depression and antidepressant treatment response. Eur Neuropsychopharmacol. 2015;25(6):864–872.
  • Cui J, Gong C, Cao B, et al. MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA. Exp Ther Med. 2018;15(5):4349–4355.
  • Yi Y, Liu Y, Wu K, et al. The core genes involved in the promotion of depression in patients with ovarian cancer. Oncol Lett. 2019;18(6):5995–6007.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.